# Microbiote intestinal et développement du système immunitaire

- **DOI:** [10.1051/medsci/20163211011](https://doi.org/10.1051/medsci/20163211011)
- **Rating:** Sound (3.5 out of 5)
- **Verdict:** A clear, well-structured 2016 synthesis of gut microbiota and immune development anchored on SFB as a model, constrained by an almost entirely mouse-based evidence base.
- **Framework version:** v5.0
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-06-12
- **Evaluation page:** https://www.nabu.science/paper/10.1051%2Fmedsci%2F20163211011

## Strengths

- **Logical, traceable mechanistic argument structure** The review progresses coherently from the physical epithelial barrier through innate immune cells and innate lymphoid cells to adaptive T-cell and IgA responses, with each section advancing a clear reasoning chain from colonization to barrier construction to homeostatic regulation.
  - Dimension: methodological rigour
  - Location: Main text sections; Figure 1
- **Calibrated hedging of mouse-to-human claims** Throughout, the review distinguishes established murine findings from uncertain human relevance, and the conclusion explicitly states that the type bacterium SFB remains to be formally demonstrated in humans.
  - Dimension: reporting
  - Location: Conclusion p.967; hedging language throughout
- **Substantive engagement with the field literature** The review marshals 42 references spanning foundational and contemporaneous primary research, including landmark SFB and Treg-induction studies, supporting key claims with specific citations to high-impact sources.
  - Dimension: positioning
  - Location: Reference list; refs 22-23, 27-28

## Limitations

- **Limited engagement with gnotobiotic model limits** The entire mechanistic framework rests on gnotobiotic mouse studies, yet the translational limitations of this model are confined to a brief conclusion rather than developed in depth.
  - Dimension: positioning
  - Location: Limitation confined to conclusion p.967
- **Incremental rather than novel synthesis** The review updates and contextualizes the conceptual framework established in the authors' prior syntheses rather than advancing a new framework, limiting its standing as an original contribution.
  - Dimension: contribution
  - Location: Sections relative to ref 18 (Nat Rev Immunol 2010)
- **Mouse-centric evidence limits translation** Findings sit at the mechanism-characterized-under-controlled-conditions stage with no implementation guidance, and the SFB-specific results carry uncertain human relevance, constraining near-term translational and cross-species transfer.
  - Dimension: application pathway
  - Location: SFB sections; conclusion p.967

## Reliability checks

No concerns (4 of 4 checks).

- **Internal coherence:** Clean. The review is internally consistent: the abstract and English summary accurately reflect the body, figure legends match the textual mechanistic descriptions, and the conclusion appropriately hedges the human relevance of SFB. No statistical, methods-results, or selective-reporting checks apply to a narrative review with no original data.
- **Research conduct:** Clean. No original empirical data, human/animal study conduct, ethics approval, or data/code claims require auditing in this narrative review. A conflict-of-interest declaration is present in the end matter. A self-citation pattern toward the authors' own prior work is present but expected for a specialist review and not a misconduct signal.
- **Reference integrity:** Clean. All 42 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17